Assessment of medication adherence among hypertensive patients: a cross-sectional study
Keywords:Patient compliance, Medication adherence, Hypertension, Hill bone compliance, HILL-BONE CHBPTS
Background: Hypertension affects around one billion individuals worldwide and is expected to increase by 29% to reach 1.56 billion by 2025. It is usually asymptomatic, chronic disorder needing lifelong treatment. The objective of this study was to study the medication adherence among hypertensive patients using hill-bone compliance to high blood pressure therapy scale (HILL-BONE CHBPTS) and to compare medication adherence in hypertensive patients with controlled and uncontrolled blood pressure.
Methods: A cross-sectional, observational study was conducted for a period of one year in the Outpatient department of Medicine in a tertiary care hospital, Navi Mumbai. A total of 129 hypertensive patients who were on at least six months on antihypertensive medications were enrolled. Blood pressure was measured and details of drug therapy were noted. Medication adherence was assessed using HILL-BONE CHBPTS and respective scores were calculated.
Results: HILL-BONE CHBPTS scores were on the higher side signifying poor medication adherence among hypertensive patients. HILL-BONE CHBPTS score correlated significantly in a positive direction with diastolic blood pressure, duration of treatment and the number of medications, As per JNC 8 recommendations, 58.9% (76) hypertensive patients were having blood pressure under control, whereas 41.1% (53) were having uncontrolled blood pressure. HILL-BONE CHBPTS scores were significantly higher (reflecting lower adherence) in hypertensive patients with uncontrolled blood pressure than those having optimally controlled blood pressure.
Conclusions: Overall the medication adherence was poor in hypertensive patients. Adherence to therapeutic regimens is an important factor in blood pressure control among hypertensive patients and needs priority. Health education related to medication adherence needs be improved in hypertensive patients.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23.
Holt EW, Muntner P, Joyce CJ, Webber L, Krousel-Wood MA. Health-related quality of life and antihypertensive medication adherence among older adults. Age Ageing. 2010;39(4):481-7.
Kale S, Patil A, Mandlecha RH. Compliance and adverse drug effects of antihypertensives in rural India. J Clin Diagn Res. 2011;5(4):775-9.
Odili VU, Oghagbon EK, Ugwa NA, Ochei UM. Adherence to International guidelines in the management of hypertension in a tertiary hospital in Nigeria. Trop J Pharm Res. 2008;7(2):945-52.
Chelkeba L, Dessie S. Antihypertension medication adherence and associated factors at Dessie. Int J Res Med Sci. 2013;1(3):191-7.
Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49(1):69-75.
Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345(7):479-86.
Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32(6):1170-7.
Brown MT, Bussell JK. Medication Adherence: WHO Cares?. Mayo Clin Proc. 2011;86(4):304-14.
Ramli A, Ahmad NS, Paraidathathu T. Medication adherence among hypertensive patients of primary health clinics in Malaysia. Patient Prefer Adherence. 2012;6:613-22.
Khalil SA, Elzubier AG. Drug compliance among hypertensive patients in Tabuk, Saudi Arabia. J Hypertens. 1997;15(5):561-5.
Elzubier AG, Husain AA, Suleiman IA, Hamid ZA. Drug compliance among hypertensive patients in Kassala, eastern Sudan. East Mediterr Health J. 2000;6(1):100-5.
Osamor PE, Owumi BE. Factors associated with treatment compliance in hypertension in Southwest Nigeria. J Health Popul Nutr. 2011;29(6):619-28.
Delamater AM. Improving patient adherence. Clin Diabetes. 2006;24:71-7.
Meichenbaum D, Turk DC. Facilitating treatment adherence: a practitioner’s Guidebook. New York, NY: Plenum Press; 1987.
Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028-35.
Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44-7.
Okoro RN, Ngong CK. Assessment of patient's antihypertensive medication adherence level in non-comorbid hypertension in a tertiary hospital in Nigeria. Int J Pharm Biomed Sci. 2012;3(2):47-54.
Biradar SS, Rajashekhar K, Srinivas R, Raju SA. Assessment of pharmacist mediated patient counseling on medication adherence in hypertension pateints of south Indian city. International Research Journal of Pharmacy. 2012;3:251-5.
Dennis T, Meera NK, Binny K, Sekhar MS, Kishore G, Sashidharan S. Medication adherence and associated barriers in hypertension management in India. CVD Prev Control. 2011;6(1):9-13.
Santra G. Assessment of adherence to cardiovascular medicines in rural population: an observational study in patients attending a tertiary care hospital. Indian J Pharmacol. 2015;47(6):600-4.
Navya CJ, Naveen R, Ashwini GS, Manu A, Steve J, Singh J, et al. Adherence to medication among patients with hypertension and diabetes mellitus in selected tea estates in South India. JIMSA. 2015;28(1):16-17.
Venkatachalam J, Abrahm SB, Singh Z, Stalin P, Sathya GR. Determinants of patient’s adherence to hypertension medications in a rural population of Kancheepuram District in Tamil Nadu, South India. Indian J Community Med. 2015;40(1):33-7.
Kim MT, Hill MN, Bone LR and Levine DM. Development and testing of the hill-bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15(3):90-6.
Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis. 2006;16(1):286-91.
Krousel-Wood M, Muntner P, Jannu A, Desalvo K, Re RN. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci. 2005;330(3):128-33.
Song Y, Han HR, Song HJ, Nam S, Nguyen T, Kim MT. Psychometric evaluation of hill-bone medication adherence subscale. Asian Nurs Res (Korean Soc Nurs Sci). 2011;5(3):183-8.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA. 2014;311(5):507-20.
Mafutha GN, Wright SCD. Compliance or non-compliance of hypertensive adults to hypertension management at three primary healthcare day clinics in Tshwane. Curationis. 2013;36(1):E1-6.
Marshall IJ, Wolfe CD, McKevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012;345:e3953.
Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19(4):357-62.
Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269-86.
Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26:1408-12.
Iihara N, Tsukamoto T, Morita S, Miyoshi C, Takabatake K, Kurosaki Y. Beliefs of chronically ill Japanese patients that lead to intentional non-adherence to medication. J Clin Pharm Ther. 2004;29:417-24.
Iskedjian M, Einarson TR, MacKeigan LD, Shear N, Addis A, Mittmann N, et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther. 2002;24:302-16.
Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296-310.
Dhanireddy KK, Maniscalco J, Kirk AD. Is tolerance induction the answer to adolescent non-adherence? Pediatr Transplant. 2005;9:357-63.
Sharkness CM, Snow DA. The patient’s view of hypertension and compliance. Am J Prev Med. 1992;8:141-6.
Caro JJ, Salas M, Speckman JL. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160:31-7.
Salanitro AH, Funkhouser E, Agee BS, Allison JJ, Halanych JH, Houston TK, et al. Multiple uncontrolled conditions and blood pressure medication intensification: an observational study. Implement Sci. 2010;5(55):1-9.
Zachariah MG, Thankappan KR, Alex SC, Sarma PS, Vasan RS. Prevalence, correlates, awareness, treatment, and control of hypertension in a middle-aged urban population in Kerala. Indian Heart J. 2003;55(3):245-51.
Weinberger MH, Glazer RD, Crikelair NA, Chiang YT. Achieving blood pressure goal: initial therapy with valsartan/hydrochlorothiazide combination compared with monotherapy. J Hum Hypertens. 2010;24(12):823-30.
Lalić J, Radovanović RV, Mitić B, Nikolić V, Spasić A, Koraćević G. Medication adherence in outpatients with arterial hypertension. Acta Facultatis Medicae Naissensis. 2013;30(4):209-18.
Khan GM, Thapa RK, Khakurel A, Shrestha G, Katila N, Bhurtel S. Medication adherence and blood pressure control among hypertensive patients of Pokhara valley. JHAS. 2013;3(1):64-7.
Gupta R, Guptha S. Strategies for initial management of hypertension. Indian J Med Res. 2010;132(5):531-42.
Haynes JM, Sweeney EL. The effect of telephone appointment-reminder calls on outpatient absenteeism in a pulmonary function laboratory. Respir Care. 2006;51(1):36-9.